Back to Search
Start Over
The Anti-α4β7 Integrin Therapeutic Antibody for Inflammatory Bowel Disease, Vedolizumab, Ameliorates Eosinophilic Esophagitis: a Novel Clinical Observation.
- Source :
-
The American journal of gastroenterology [Am J Gastroenterol] 2018 Aug; Vol. 113 (8), pp. 1261-1263. Date of Electronic Publication: 2018 Jun 12. - Publication Year :
- 2018
- Subjects :
- Adult
Antibodies, Monoclonal, Humanized administration & dosage
Crohn Disease complications
Eosinophilic Esophagitis complications
Gastrointestinal Agents administration & dosage
Humans
Infliximab administration & dosage
Infliximab therapeutic use
Male
Antibodies, Monoclonal, Humanized therapeutic use
Crohn Disease drug therapy
Eosinophilic Esophagitis drug therapy
Gastrointestinal Agents therapeutic use
Integrins antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1572-0241
- Volume :
- 113
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- The American journal of gastroenterology
- Publication Type :
- Report
- Accession number :
- 29895980
- Full Text :
- https://doi.org/10.1038/s41395-018-0145-1